Item Type | Name |
Academic Article
|
Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria.
|
Academic Article
|
Treatment of chronic autoimmune urticaria with omalizumab.
|
Concept
|
Histamine
|
Concept
|
Histamine H2 Antagonists
|
Concept
|
Histamine H1 Antagonists
|
Concept
|
Histamine Release
|
Concept
|
Histamine Antagonists
|
Academic Article
|
Evaluation of a patient with cold and cholinergic urticaria.
|
Academic Article
|
Mediators of urticaria and angioedema.
|
Academic Article
|
Assessment of tissue fluid histamine levels in patients with urticaria.
|
Academic Article
|
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.
|
Academic Article
|
Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
|
Academic Article
|
RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils.
|
Academic Article
|
Cytokine stimulation of human basophil histamine release.
|
Academic Article
|
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.
|
Academic Article
|
Histamine releasing factors.
|
Academic Article
|
IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3.
|
Academic Article
|
Histamine-releasing factors.
|
Academic Article
|
Histamine releasing factors and cytokine-dependent activation of basophils and mast cells.
|
Academic Article
|
Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor.
|
Academic Article
|
Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine.
|
Academic Article
|
Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes.
|
Academic Article
|
Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release.
|
Academic Article
|
Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE.
|
Academic Article
|
Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors.
|
Academic Article
|
Purification and further characterization of human mononuclear cell histamine-releasing factor.
|
Academic Article
|
Recombinant human interleukin-1 beta causes histamine release from human basophils.
|
Academic Article
|
Activation of plasma Hageman factor and kallikrein in ongoing allergic reactions in the skin.
|
Academic Article
|
The role of cyproheptadine in the treatment of cold urticaria.
|
Academic Article
|
Chronic urticaria. Possible causes, suggested treatment alternatives.
|
Academic Article
|
The physical urticarias.
|
Academic Article
|
Histamine release and therapy of severe dermatographism.
|
Academic Article
|
Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies.
|
Academic Article
|
Exercise-induced anaphylaxis as a manifestation of cholinergic urticaria.
|
Academic Article
|
Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria.
|
Academic Article
|
Exercise-induced hives.
|
Academic Article
|
Identification of a new physically induced urticaria: cold-induced cholinergic urticaria.
|
Academic Article
|
Chemokines as allergic mediators--relationship to histamine-releasing factors.
|
Academic Article
|
Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1.
|
Academic Article
|
Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family.
|
Academic Article
|
In vivo studies of mediator release in cold urticaria and cholinergic urticaria.
|
Academic Article
|
Hereditary vibratory angioedema: confirmation of histamine release in a type of physical hypersensitivity.
|
Academic Article
|
Mediator release from basophil granulocytes in chronic myelogenous leukemia.
|
Academic Article
|
Chemokines and the allergic response.
|
Academic Article
|
Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells.
|
Academic Article
|
Chemokines in seasonal allergic rhinitis.
|
Academic Article
|
Pattern of nasal secretions during experimental influenza virus infection.
|
Academic Article
|
Relationship of histamine-releasing factors and histamine-releasing inhibitory factors to chemokine group of cytokine.
|
Academic Article
|
Further characterization of histamine releasing chemokines present in fractionated supernatants derived from human mononuclear cells.
|
Academic Article
|
Assessment of autoimmunity in patients with chronic urticaria.
|
Academic Article
|
Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria.
|
Academic Article
|
An IgE-dependent histamine-releasing factor (HRF) identical to a previously described human protein (P23)
|
Academic Article
|
IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera.
|
Academic Article
|
Chronic urticaria: pathogenesis and treatment.
|
Academic Article
|
Comments regarding 'Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells' by Asero et al. A.P. Kaplan.
|
Academic Article
|
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli.
|
Academic Article
|
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
|
Academic Article
|
Chronic urticaria: what is new, where are we headed.
|
Academic Article
|
What the first 10,000 patients with chronic urticaria have taught me: a personal journey.
|
Academic Article
|
Pathogenesis of chronic urticaria.
|
Academic Article
|
Pathogenesis and treatment of chronic urticaria.
|
Academic Article
|
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
|
Academic Article
|
Therapy of chronic urticaria: a simple, modern approach.
|
Academic Article
|
The maddening itch: an approach to chronic urticaria.
|
Academic Article
|
Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy.
|
Academic Article
|
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
|
Academic Article
|
Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria.
|
Academic Article
|
Basophil histamine release in patients with chronic spontaneous urticaria: Optimize or minimize.
|
Academic Article
|
Treatment of urticaria: a clinical and mechanistic approach.
|
Academic Article
|
Complement dependence of histamine release in chronic urticaria.
|
Academic Article
|
A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.
|
Academic Article
|
Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid.
|
Academic Article
|
Clinical practice. Chronic urticaria and angioedema.
|
Academic Article
|
A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria.
|
Academic Article
|
Diagnosis and treatment of chronic spontaneous urticaria.
|
Academic Article
|
Relationship of Histamine-Releasing Factors to the Human Intercrine/Chemokine Group of Cytokine-Like Molecules.
|